Articles published by Veracyte, Inc.
Veracyte Announces Third Quarter 2022 Financial Results
November 02, 2022
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
Veracyte Data Presented at ATA Annual Meeting Provide New Insights into Molecular Underpinnings of Thyroid Cancer
October 24, 2022
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
Veracyte Names John Leite, Ph.D., as General Manager of Pulmonology & Market Access
September 13, 2022
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
Veracyte to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
September 01, 2022
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
Veracyte Appoints Eliav Barr, M.D., to Its Board of Directors
August 11, 2022
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
Veracyte Announces Second Quarter 2022 Financial Results
August 02, 2022
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
New Data Show Strong Performance of Veracyte’s Afirma GSC in Real-World Clinical Practice
June 20, 2022
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
Veracyte to Present at Upcoming Investor Conferences
May 26, 2022
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
Veracyte Announces New Consensus Data from PROCURE Study Presented at ESMO Breast Cancer 2022
May 04, 2022
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.